Pharmaceutical
February 7, 2011
According to the Associated Press, Pfizer Inc. said it will expand its European business by acquiring Ferrosan''s consumer health care business which includes vitamins and skincare products. The drugmaker did
Read More
January 31, 2011
According to the Associated Press, Pfizer Inc. has named Dr. Yvonne Greenstreet as the senior vice president and head of medicine development for the specialty care business unit, effective Tuesday.
Read More
January 31, 2011
The Associated Press reports, a federal jury in Texas has ordered Johnson & Johnson and a subsidiary to pay $482 million in damages to an inventor who claimed the health
Read More
January 24, 2011
Genzyme Corp has announced it will build a new plant in Belgium to produce Lumizyme, its treatment for Pompe disease, a rare genetic disease. Lumizyne is known as Myozyme outside
Read More
January 6, 2011
India PRwire reports, Global Pharmaceutical and Chemical Company, Merck Limited, opened its new Application and Technology Centre at Nerul, Navi Mumbai. Spread over 1700 sq. ft., the state-of-the-art Centre will
Read More
December 20, 2010
The Associated Press reports, Swiss pharmaceutical company Novartis AG says it plans to invest $500 million in Russia over a five-year period. Novartis says the investment will include the construction
Read More
December 13, 2010
The Associated Press reports, French pharmaceutical group Sanofi-Aventis is extending its unsolicited $18.5 billion takeover offer for U.S.-based biotech company Genzyme until Jan. 21. The previous $69-per-share offer expired
Read More
December 6, 2010
After more than four years at the helm, Pfizer Inc.’s President and CEO Jeffrey Kindler has resigned from the company, reports the Associated Press. The New York-based pharmaceutical company''s
Read More
November 29, 2010
The Press Association reports, GlaxoSmithKline will create around 1,000 jobs and invest £500 million in manufacturing following tax reforms announced by the Government. GlaxoSmithKline said a ten percent reduction
Read More
November 8, 2010
Pfizer Inc.’s experimental pill for rheumatoid arthritis reduced pain and inflammation for 71 percent of patients in a study that may help the company with $12 billion in yearly
Read More